Early diagnosis, treatment of AMD essential for lifelong healthy vision

Article

Vision loss in relation to eye disease and treatment response was tracked in nearly 5,000 patients over 20 years.

 

San Francisco-Despite the recent discovery of sight-saving drugs and advances in disease prevention, age-related macular degeneration (AMD) still causes vision loss in approximately 15% of Americans aged 85 and older, according to a study published recently in Ophthalmology.

The Beaver Dam Eye Study tracked vision loss in relation to eye disease and treatment response in nearly 5,000 patients over a 20-year period.

“This study paints a clearer picture of key threats to older Americans’ vision, such as AMD,” said Ronald Klein, MD, lead researcher for the study conducted at the University of Wisconsin School of Medicine and Public Health, Madison. “It is especially relevant for healthcare planners, who face a tripling of the elderly population in the U.S. More people than ever will live into their seventh, eighth, or ninth decades, the very years when they’ll be most vulnerable to age-related eye diseases.”

Healthy vision is essential to seniors’ ability to enjoy a good quality of life. From maintaining the ability to read and drive to reducing the risk of injury from falls and other accidents, keeping eyes healthy into advanced age is crucial.

Recent Videos
The Vision Council CEO Ashley Mills overviews what is new and exciting at this year's show, running from February 19-22 in Orlando, Florida, and provides a free registration code for those still looking to register.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
© 2025 MJH Life Sciences

All rights reserved.